IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
13 hedge funds and large institutions have $2.37M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.27M | |
| 2 | +$81.1K | |
| 3 | +$69.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$36.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$30.7K |
Top Sellers
| 1 | -$646K | |
| 2 | -$476K | |
| 3 | -$44.3K | |
| 4 |
Bank of New York Mellon
New York
|
-$18K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$13K |